Lucid Diagnostics Inc. (LUCD): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$872.0K
Year ended 2025-12-31
$875.0K
Trailing 12 months to 2026-06-30
-23.3%
3-year compound annual growth
$2.50M2021-12-31: $4.0K2022-12-31: $1.94M2023-12-31: $2.50M2024-12-31: $1.17M2025-12-31: $872.0K$872.0K
2021-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$872.0K-25.3%2026-03-25, From 2025-01-01
2024-12-31$1.17M-53.3%2026-03-25, From 2024-01-01
2023-12-31$2.50M+29.1%2025-03-24, From 2023-01-01
2022-12-31$1.94Mn/m2024-03-25, From 2022-01-01
2021-12-31$4.0Kn/a2023-03-14, From 2021-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Lucid Diagnostics Inc. (LUCD)2025-12-31$872.0K-25.3%
Picard Medical, Inc. (PMI)2025-12-31$163.0K-27.9%
Cerenome, Inc. (CNSY)2025-12-31$445.0K-49.0%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$1.16M-3.6%
Tenon Medical, Inc. (TNON)2025-12-31$262.0K-35.8%
INVO Fertility, Inc. (IVF)2025-12-31$677.4K-26.3%
Beyond Air, Inc. (XAIR)2026-03-31$3.10M+3.3%
QHSLab, Inc. (USAQ)2025-12-31$90.7K-38.1%
InspireMD, Inc. (NSPR)2025-12-31$476.00M+70.0%

Compare LUCD, PMI, CNSY, INBS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗